For stroke patients undergoing mechanical thrombectomy, adjunctive intra-arterial thrombolytics fell short for further ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...

Dr. Nima Aghaebrahim, a neurointerventionalist at Baptist Health, explains why "time is brain" when treating a stroke. Then, ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...